======= LIPT2 ======= == Gene Information == * **Official Symbol**: LIPT2 * **Official Name**: lipoyl(octanoyl) transferase 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=387787|387787]] * **UniProt**: [[https://www.uniprot.org/uniprot/A6NK58|A6NK58]] * **Interactions**: [[https://thebiogrid.org/search.php?search=LIPT2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LIPT2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/617659|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a mitochondrial protein that catalyzes the transfer of octanoic acid to lipoate-dependent enzymes such as octanoyl-ACP. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]. * **UniProt Summary**: Catalyzes the transfer of endogenously produced octanoic acid from octanoyl-acyl-carrier-protein onto the lipoyl domains of lipoate-dependent enzymes, which catalyze essential redox reactions (PubMed:28757203). Lipoyl-ACP can also act as a substrate although octanoyl-ACP is likely to be the physiological substrate (By similarity). {ECO:0000250, ECO:0000269|PubMed:28757203}. |BPL LplA LipB| |lipoyl(octanoyl) transferase activity| |octanoyl transferase activity (acting on glycine-cleavage complex H protein)| |positive regulation of oxygen metabolic process| |regulation of oxygen metabolic process| |protein lipoylation| |protein-cofactor linkage| |ligase activity| |protein maturation| |peptidyl-lysine modification| |mitochondrial matrix| |peptidyl-amino acid modification| |mitochondrion| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp241|QNZ 0.01μM R05 exp241]]|-2.36| |[[:results:exp439|QNZ 0.01μM R08 exp439]]|-2.27| |[[:results:exp102|Nifuroxazide 5μM R03 exp102]]|-2.14| |[[:results:exp129|Isonicotinamide 500μM R03 exp129]]|-1.86| |[[:results:exp493|IL-3 9ng/ml R08 exp493]]|-1.8| |[[:results:exp432|YM155 0.001μM R08 exp432]]|-1.78| |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|1.82| |[[:results:exp519|RS-1 10μM R08 exp519]]|1.84| |[[:results:exp183|IU1-C 25μM R04 exp183]]|1.85| |[[:results:exp359|FK-506 30μM R07 exp359]]|1.99| |[[:results:exp269|Bisphenol A 100μM R06 exp269]]|2.08| |[[:results:exp116|AICAR 240μM R03 exp116]]|2.37| |[[:results:exp288|HMS-I2 10μM R06 exp288]]|2.39| |[[:results:exp465|Cannabidiol 13μM R08 exp465]]|2.61| |[[:results:exp450|Artemisinin 50μM R08 exp450]]|2.67| ^Gene^Correlation^ |[[:human genes:l:lipt1|LIPT1]]|0.631| |[[:human genes:l:lias|LIAS]]|0.524| |[[:human genes:g:gcsh|GCSH]]|0.508| |[[:human genes:t:tpk1|TPK1]]|0.503| |[[:human genes:s:slc25a19|SLC25A19]]|0.488| |[[:human genes:i:iba57|IBA57]]|0.454| |[[:human genes:f:fdx1|FDX1]]|0.433| |[[:human genes:d:dld|DLD]]|0.431| |[[:human genes:g:glrx5|GLRX5]]|0.431| |[[:human genes:a:abhd11|ABHD11]]|0.42| |[[:human genes:a:aasdhppt|AASDHPPT]]|0.412| |[[:human genes:n:nfu1|NFU1]]|0.41| |[[:human genes:s:suclg1|SUCLG1]]|0.403| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 812 * **Expression level (log2 read counts)**: 0.89 {{:chemogenomics:nalm6 dist.png?nolink |}}